The FDA has approved Norditropin FlexPro (somatropin [rDNA origin] injection, from Novo Nordisk), a pre-filled injection pen, for patients with growth hormone disorders.
Sign in with your MPR account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH A MPR ACCOUNT
Enter your MPR registration email address to receive a new password.